Page last updated at 12:04 GMT, Monday, 25 May 2009 13:04 UK

Floppy baby syndrome breakthrough

Ultrasound scan of a 15 week old foetus
It may be possible to start treating affected babies during pregnancy

Scientists believe they have made a breakthrough in the treatment of a severe muscle disease that causes floppy baby syndrome.

Most babies born with the rare disorder are severely paralysed and the majority die before the age of one.

The Australian team was able to cure affected mice by replacing a missing muscle protein.

A UK expert said the findings, in the Journal of Cell Biology, could lead to improved movement for affected babies.

This is an important step towards one day hopefully being able to better the lives of human patients
Dr Kristen Nowak, Western Australian Institute for Medical Research

The team focussed on proteins called actins. A gene called ACTA1 controls the production of actin in skeletal muscles.

It is key to allowing muscles to contract, but children with this disease have flawed versions of the gene and so the protein is not produced.

However, the scientists had seen that some children with floppy baby syndrome were not totally paralysed at birth.

When these children were studied, it was found that heart actin - another form of the protein - was "switched on" in their skeletal muscles, when that would not normally be the case.

Heart actin is found in skeletal muscles while the baby is developing in the womb, but has almost completely disappeared by birth.

Old age

The researchers found it was possible to cure mice genetically engineered to have the recessive form of the muscle disorder by replacing the missing skeletal muscle actin with heart actin.

Dr Kristen Nowak, of the Western Australian Institute for Medical Research, who led the study, said: "The mice with floppy baby syndrome were only expected to live for about nine days, but we managed to cure them so they were born with normal muscle function, allowing them to live naturally and very actively into old age.

"This is an important step towards one day hopefully being able to better the lives of human patients - mice who were cured of the disease lived more than two years, which is very old age for a mouse."

They would be likely to have a good quality of life
Professor Dame Kay Davies, University of Oxford

The team now plan to apply their findings to human patients.

They are analysing 1,000 existing medicines to see if any could increase the amount of heart actin in skeletal muscles.

Professor Nigel Laing, head of the research group, said: "Current therapies only target the effects of these conditions, not the condition itself - we hope our approach could lead to a much greater improvement for a range of muscle diseases."

Toxicity

Professor Dame Kay Davies, of the University of Oxford, helped create the mice used in the study. She said the findings were promising.

"What we can't guarantee is if we can find a chemical to increase levels of heart actin enough.

"But we do have an idea of what kind of compounds might work."

Professor Davies added: "If we could then screen every pregnancy, we could start treating this towards the end of foetal life.

"It could go some way past giving just some movement, but it probably wouldn't be possible to enable children to run around.

"However they would be likely to have a good quality of life."

Floppy baby syndrome is distinct from babies who are deemed "floppy" because the development of their gross motor skills such as sitting and crawling is delayed.



Print Sponsor


SEE ALSO
Drug 'mends' muscular dystrophy
22 Apr 07 |  Health
Stem cells 'treat muscle disease'
15 Nov 06 |  Health
Muscular dystrophy breakthrough
26 Nov 01 |  Health

RELATED INTERNET LINKS
The BBC is not responsible for the content of external internet sites


FEATURES, VIEWS, ANALYSIS
Has China's housing bubble burst?
How the world's oldest clove tree defied an empire
Why Royal Ballet principal Sergei Polunin quit

BBC navigation

BBC © 2013 The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific